|Vesicles of variable sizes produced by a rapid extrusion procedure|
LD Mayer, MJ Hope, PR Cullis
Biochimica et Biophysica Acta (BBA)-Biomembranes 858 (1), 161-168, 1986
|Multidrug resistance (MDR) in cancer: mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs|
R Krishna, LD Mayer
European Journal of Pharmaceutical Sciences 11 (4), 265-283, 2000
|Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study|
PP Zandi, MC Carlson, BL Plassman, KA Welsh-Bohmer, LS Mayer, ...
Jama 288 (17), 2123-2129, 2002
|Liposomal compositions for enhanced retention of bioactive agents|
MB Bally, NL Boman, PR Cullis, LD Mayer
US Patent 5,595,756, 1997
|The course and malleability of aggressive behavior from early first grade into middle school: Results of a developmental epidemiologically‐based preventive trial|
SG Kellam, GW Rebok, N Ialongo, LS Mayer
Journal of Child Psychology and Psychiatry 35 (2), 259-281, 1994
|Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles|
LD Mayer, MJ Hope, PR Cullis, AS Janoff
Biochimica et Biophysica Acta (BBA)-Biomembranes 817 (1), 193-196, 1985
|Generation of multilamellar and unilamellar phospholipid vesicles|
MJ Hope, MB Bally, LD Mayer, AS Janoff, PR Cullis
Chemistry and physics of lipids 40 (2-4), 89-107, 1986
|Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly (ethylene glycol)|
C Allen, N Dos Santos, R Gallagher, GNC Chiu, Y Shu, WM Li, ...
Bioscience reports 22 (2), 225-250, 2002
|Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice|
LD Mayer, LCL Tai, DSC Ko, D Masin, RS Ginsberg, PR Cullis, MB Bally
Cancer research 49 (21), 5922-5930, 1989
|The short-term impact of two classroom-based preventive interventions on aggressive and shy behaviors and poor achievement|
LJ Dolan, SG Kellam, CH Brown, L Werthamer-Larsson, GW Rebok, ...
Journal of Applied Developmental Psychology 14 (3), 317-345, 1993
|Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient|
LD Mayer, MB Bally, PR Cullis
Biochimica Et Biophysica Acta (BBA)-Biomembranes 857 (1), 123-126, 1986
|The liposomal formulation of doxorubicin|
SA Abraham, DN Waterhouse, LD Mayer, PR Cullis, TD Madden, ...
Methods in enzymology 391, 71-97, 2005
|Antihypertensive medication use and incident Alzheimer disease: the Cache County Study|
AS Khachaturian, PP Zandi, CG Lyketsos, KM Hayden, I Skoog, ...
Archives of neurology 63 (5), 686-692, 2006
|Incidence of AD may decline in the early 90s for men, later for women: The Cache County study|
RA Miech, JCS Breitner, PP Zandi, AS Khachaturian, JC Anthony, ...
Neurology 58 (2), 209-218, 2002
|Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study|
PP Zandi, JC Anthony, KM Hayden, K Mehta, L Mayer, JCS Breitner
Neurology 59 (6), 880-886, 2002
|Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice|
LD Mayer, TO Harasym, PG Tardi, NL Harasym, CR Shew, SA Johnstone, ...
Molecular cancer therapeutics 5 (7), 1854-1863, 2006
|Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients|
LD Mayer, LCL Tai, MB Bally, GN Mitilenes, RS Ginsberg, PR Cullis
Biochimica et biophysica acta (BBA)-biomembranes 1025 (2), 143-151, 1990
|Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo|
YP Hu, G Cherton-Horvat, V Dragowska, S Baird, RG Korneluk, JP Durkin, ...
Clinical cancer research 9 (7), 2826-2836, 2003
|The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey|
TD Madden, PR Harrigan, LCL Tai, MB Bally, LD Mayer, TE Redelmeier, ...
Chemistry and physics of lipids 53 (1), 37-46, 1990
|In vivo maintenance of synergistic cytarabine: daunorubicin ratios greatly enhances therapeutic efficacy|
P Tardi, S Johnstone, N Harasym, S Xie, T Harasym, N Zisman, P Harvie, ...
Leukemia research 33 (1), 129-139, 2009